HIV and the criminalisation of drug use among people who inject drugs: a systematic review

The Lancet HIV

Volumn 4, Issue 8, 2017, Pages e357-e374

  DeBeck, Kora ^a,b   Cheng, Tessa ^a,b   Montaner, Julio S ^a,c   Beyrer, Chris ^d   Elliott, Richard ^e   Sherman, Susan ^d   Wood, Evan ^a,c   Baral, Stefan ^d  

^a BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e Canadian HIV/AIDS Legal Network   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; CRIMINAL BEHAVIOR; DRUG CONTROL; DRUG CRIMINALISATION; DRUG USE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCARCERATION; INFECTION PREVENTION; NEEDLE SHARING; PREVALENCE; PRIORITY JOURNAL; SELF INJECTION; STREET LEVEL POLICING; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CANADA; COMPLICATION; CRIME; CROSS-SECTIONAL STUDY; DRUG DEPENDENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; ISOLATION AND PURIFICATION; SUBSTANCE ABUSE; UNITED STATES;

CANADA; CRIME; CROSS-SECTIONAL STUDIES; DRUG USERS; HIV INFECTIONS; HIV-1; HUMANS; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 85019409937     PISSN: None     EISSN: 23523018     Source Type: Journal    
DOI: 10.1016/S2352-3018(17)30073-5     Document Type: Article

References (134)

1. UN Office on Drugs and Crime. World Drug Report 2016, 2016, UN Office on Drugs and Crime, New York, NY.
2. UNAIDS. The gap report. Jul 16, 2014, 2014, UNAIDS, Geneva.
3. Mathers, BM, Degenhardt, L, Phillips, B, et al., for the the 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 372 (2008), 1733–1745.
4. Wolfe, D, Carrieri, MP, Shepard, D, Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet 376 (2010), 355–366.
5. Degenhardt, L, Mathers, BM, Wirtz, AL, et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010–2012? A review of the six highest burden countries. Int J Drug Policy 25 (2014), 53–60.
6. Gouws, E, Cuchi, P, on behalf of the International Collaboration on Estimating HIV Incidence by Modes of Transmission. Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis. Sex Transm Infect 88:suppl 2 (2012), 76–85.
7. UNAIDS. AIDS by the numbers: AIDS is not over, but it can be. http://www.unaids.org/en/resources/documents/2016/AIDS-by-the-numbers, Nov 21, 2016 (accessed April 4, 2017).
8. WHO. Global update on HIV treatment 2013: results, impact and opportunities, 2013, World Health Organization, Geneva.
9. Montaner, JSG, Hogg, R, Wood, E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368 (2006), 531–536.
10. Palella, FJJ, Baker, RK, Moorman, AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquire Immune Defic Syndr 43 (2006), 27–34.
11. Montaner, JSG, Lima, VD, Harrigan, PR, et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the “HIV treatment as prevention” experience in a Canadian setting. PLoS One, 9, 2014, e87872.
12. Choopanya, K, Martin, M, Suntharasamai, P, et al., for the Bangkok Tenofovir Study Group. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 381 (2013), 2083–2090.
13. Eramova, I, Matic, S, Munz, M, HIV/AIDS treatment and care: clinical protocols for the WHO European region, 2007, World Health Organization, Copenhagen.
14. UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. Oct 8, 2014, 2014, UNAIDS, Geneva.
15. Degenhardt, L, Mathers, B, Vickerman, P, Rhodes, T, Latkin, C, Hickman, M, Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 376 (2010), 285–301.
16. Gowing, L, Farrell, MF, Bornemann, R, Sullivan, LE, Ali, R, Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev, 2011, 2011 CD004145.
17. The Global Fund. Turning the tide against HIV and tuberculosis: global fund investment guidance for Eastern Europe and Central Asia. Aug 14, 2014, 2014, The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva http://www.globalfundadvocatesnetwork.org/wp-content/uploads/2015/03/Global-Fund-Investment-Guidance-for-EECA_en.pdf (accessed April 4, 2017).
18. Strathdee, SA, Hallett, TB, Bobrova, N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 376 (2010), 268–284.
19. Jürgens, R, HIV/AIDS in prisons: final report. June 20, 1996, 1996, Canadian HIV/AIDS Legal Network, Montreal, QC.
20. Shewan, D, Gemmell, M, Davies, JB, Behavioural change amongst drug injectors in Scottish prisons. Soc Sci Med 39 (1994), 1585–1586.
21. Ball, A, Des Jarlais, DC, Donoghoe, MC, et al. Multi-centre study on drug injecting and risk of HIV infection: a report prepared on behalf of the WHO International Collaborative Group for the Programme on Substance Abuse, 1995, World Health Organization, Geneva.
22. Beyrer, C, Jittiwutikarn, J, Teokul, W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav 7 (2003), 153–161.
23. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Int Med 151 (2009), 264–269.
24. Downs, SH, Black, N, The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal Epidemiol Community Health 52 (1998), 377–384.
25. Marshall, BD, Werb, D, Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 105 (2010), 991–1002.
26. Rosenblum, D, Jones, M, Did the Taliban's opium eradication campaign cause a decline in HIV infections in Russia?. Subst Use Misuse 48 (2013), 470–476.
27. Rhodes, T, Bivol, S, “Back then” and “nowadays”: social transition narratives in accounts of injecting drug use in an East European setting. Soc Sci Med 74 (2012), 425–433.
28. Plugge, E, Yudkin, P, Douglas, N, Changes in women's use of illicit drugs following imprisonment. Addiction 104 (2009), 215–222.
29. Wong, J, Marshall, BDL, Kerr, T, Lai, C, Wood, E, Addiction treatment experience among a cohort of street-involved youths and young adults. Journal Child Adoles Subst 18 (2009), 398–409.
30. Cunningham, JK, Liu, L, Muramoto, M, Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting. Addiction 103 (2008), 1174–1186.
31. Koulierakis, G, Drug use and related precautions prior to imprisonment, inside prison and intentions after release among Greek inmates. Addict Res Theory 14 (2006), 217–233.
32. Friedman, SR, Pouget, ER, Chatterjee, S, et al. Drug arrests and injection drug deterrence. Am J Public Health 101 (2011), 344–349.
33. Rondinelli, AJ, Ouellet, LJ, Strathdee, SA, et al. Young adult injection drug users in the United States continue to practice HIV risk behaviors. Drug Alcohol Depend 104 (2009), 167–174.
34. Milloy, MJ, Wood, E, Tyndall, M, Lai, C, Montaner, J, Kerr, T, Recent incarceration and use of a supervised injection facility in Vancouver, Canada. Addict Res Theory 17 (2009), 538–545.
35. Werb, D, Hayashi, K, Fairbairn, N, et al. Drug use patterns among Thai illicit drug injectors amidst increased police presence. Subste Abuse Treat Prev Policy, 4, 2009, 16.
36. Friedman S, Brady J, Tempalski B, Flom P, Cooper H. Increasing arrests for heroin and cocaine possession (“hard-drug arrests”) are not associated with decreasing proportions of injection drug users (IDU) in metropolitan statistical areas (MSAs). AIDS 2008—XVII International AIDS Conference; Mexico City, Mexico; Aug 3–8, 2008. TUAE0202 (abstr).
37. Johnson, BD, Golub, AL, Deren, S, Des Jarlais, DC, Fuller, C, Vlahov, D, The nonimpact of the expanded syringe access program upon heroin use, injection behaviours, and crime indicators in New York City and State. Justice Research and Policy 8 (2006), 27–49.
38. Kerr, T, Stoltz, JA, Tyndall, M, et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ 332 (2006), 220–222.
39. Palepu, A, Tyndall, MW, Joy, R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend 84 (2006), 188–194.
40. Cardoso, MN, Caiaffa, WT, Mingoti, SA, AIDS incidence and mortality in injecting drug users: the AjUDE-Brasil II Project. Cadernos de Saude Publica 22 (2006), 827–837.
41. Huo, D, Bailey, SL, Ouellet, LJ, Cessation of injection drug use and change in injection frequency: the Chicago Needle Exchange Evaluation Study. Addiction 101 (2006), 1606–1613.
42. Chen, HT, Tuner, N, Chen, CJ, Lin, H-Y, Liang, S, Wang, S, Correlations between compulsory drug abstinence treatments and HIV risk behaviors among injection drug users in a border city of South China. AIDS Educ Prev 25 (2013), 336–348.
43. Hayashi, K, Ti, L, Fairbairn, N, et al. Drug-related harm among people who inject drugs in Thailand: summary findings from the Mitsampan Community Research Project. Harm Reduct J, 10, 2013, 21.
44. DeBeck, K, Kerr, T, Li, K, Milloy, M, Montaner, J, Wood, E, Incarceration and drug use patterns among a cohort of injection drug users. Addiction 104 (2009), 69–76.
45. Friedman, SR, Cooper, HL, Tempalski, B, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS, 20, 2006, 93.
46. Caiaffa, WT, Bastos, FI, Freitas, LL, et al. The contribution of two Brazilian multi-center studies to the assessment of HIV and HCV infection and prevention strategies among injecting drug users: the AjUDE-Brasil I and II Projects. Cadernos de Saude Publica 22 (2006), 771–782.
47. Gu, J, Xu, HF, Lau, JTF, et al. Situation-specific factors predicting nonadherence to methadone maintenance treatment: a cross-sectional study using the case-crossover design in Guangzhou, China. AIDS Care 26 (2014), S107–S112.
48. Kerr, T, Hayashi, K, Ti, L, Kaplan, K, Suwannawong, P, Wood, E, The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. Int J Drug Policy 25 (2014), 171–174.
49. Rahnama, R, Mohraz, M, Mirzazadeh, A, et al. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran. Int J Drug Policy 25 (2014), 717–723.
50. Madden, A, Wodak, A, Australia's response to HIV among people who inject drugs. AIDS Educ Prev 26 (2014), 234–244.
51. Huang, YF, Yang, JY, Nelson, KE, et al. Changes in HIV incidence among people who inject drugs in Taiwan following introduction of a harm reduction program: a study of two cohorts. PLoS Med, 11, 2014, e1001625.
52. Werb D. Estimating the number of HIV and hepatitis C cases averted through the implementation of federal prison-based needle exchange programs in Canada. AIDS 2014; 20th International AIDS Conference; Melbourne, VIC, Australia; July 20–25, 2014. LBPE31 (abstr).
53. Ngo H, Mundy G, Neukom J. Factors associated with needle syringe sharing in Vietnam. AIDS 2014; 20th International AIDS Conference; Melbourne, VIC, Australia; July 20–25, 2014. MOPE117 (abstr).
54. Lunze, K, Raj, A, Cheng, DM, et al. Punitive policing and associated substance use risks among HIV-positive people in Russia who inject drugs. J Int AIDS Soc, 17, 2014, 19043.
55. Beletsky, L, Heller, D, Jenness, SM, Neaigus, A, Gelpi-Acosta, C, Hagan, H, Syringe access, syringe sharing, and police encounters among people who inject drugs in New York City: a community-level perspective. Int J Drug Policy 25 (2014), 105–111.
56. Izenberg, JM, Bachireddy, C, Soule, M, Kiriazova, T, Dvoryak, S, Altice, FL, High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes. Drug Alcohol Depend 133 (2013), 154–160.
57. Ti, L, Hayashi, K, Kaplan, K, et al. HIV test avoidance among people who inject drugs in Thailand. AIDS Behav 17 (2013), 2474–2478.
58. Chakrapani, V, Kamei, R, Kipgen, H, Kh, JK, Access to harm reduction and HIV-related treatment services inside Indian prisons: experiences of formerly incarcerated injecting drug users. Int J Prison Health 9 (2013), 82–91.
59. Wen-Jing, Y, Wen-Ing, T, Jih-Heng, L, Current status of substance abuse and HIV in Taiwan. J Food Drug Anal 21 (2013), s27–s32.
60. Ti, LP, Wood, E, Shannon, K, Feng, C, Kerr, T, Police confrontations among street-involved youth in a Canadian setting. Int J Drug Policy 24 (2013), 46–51.
61. Hayashi, K, Policing and public health: experiences of people who inject drugs in Bangkok, Thailand. PhD thesis, 2013, University of British Columbia, BC, 1–165.
62. Lin, TY, Chen, VCH, Lee, CH, et al. Prevalence, correlates, and risk perception of HIV infection among heroin users in Central Taiwan. Kaohsiung J Med Sci 29 (2013), 673–679.
63. Beletsky, L, Lozada, R, Gaines, T, et al. Syringe confiscation as an HIV risk factor: the public health implications of arbitrary policing in Tijuana and Ciudad Juarez, Mexico. J Urban Health 90 (2013), 284–298.
64. Wagner, KD, Simon-Freeman, R, Bluthenthal, RN, The association between law enforcement encounters and syringe sharing among IDUs on skid row: a mixed methods analysis. AIDS Behav 17 (2013), 2637–2643.
65. Pan, SW, Christian, CWM, Pearce, ME, et al. The Cedar Project: impacts of policing among young Aboriginal people who use injection and non-injection drugs in British Columbia, Canada. Int J Drug Policy 24 (2013), 449–459.
66. Smith, K, Bartlett, N, Wang, N, A harm reduction paradox: comparing China's policies on needle and syringe exchange and methadone maintenance. Int J Drug Policy 23 (2012), 327–332.
67. Fatseas, M, Denis, C, Serre, F, Dubernet, J, Daulouède, J-P, Auriacombe, M, Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy. AIDS Behav 16 (2012), 2082–2090.
68. Csete, J, Grob, PJ, Switzerland, HIV and the power of pragmatism: lessons for drug policy development. Int J Drug Policy 23 (2012), 82–86.
69. Lee, H, Li, J, Evaluation of a national harm reduction policy on the effectiveness of HIV/AIDS control in Taiwan. J Alcohol Drug Educ, 56, 2012, 56.
70. Cooper, HLF, Des Jarlais, DC, Tempalski, B, Bossak, BH, Ross, Z, Friedman, SR, Drug-related arrest rates and spatial access to syringe exchange programs in New York City health districts: combined effects on the risk of injection-related infections among injectors. Health Place 18 (2012), 218–228.
71. Cooper, H, Des Jarlais, D, Ross, Z, Tempalski, B, Bossak, BH, Friedman, SR, Spatial access to sterile syringes and the odds of injecting with an unsterile syringe among injectors: a longitudinal multilevel study. J Urban Health 89 (2012), 678–696.
72. Peng, EYC, Yeh, CY, Cheng, SH, et al. A case-control study of HIV infection among incarcerated female drug users: impact of sharing needles and having drug-using sexual partners. J Formos Med Assoc 110 (2011), 446–453.
73. Volkmann, T, Lozada, R, Anderson, CM, Patterson, TL, Vera, A, Strathdee, SA, Factors associated with drug-related harms related to policing in Tijuana, Mexico. Harm Reduct J, 8, 2011, 7.
74. Strathdee, SA, Lozada, R, Martinez, G, et al. Social and structural factors associated with hiv infection among female sex workers who inject drugs in the Mexico-US border region. PLoS One, 6, 2011, e19048.
75. El Dabaghi L, El Nakib M, Abdallah A. Situation assessment on drug use and HIV and AIDS in the prison setting in Lebanon. International Conference on AIDS; Vienna, Austria; July 18–23, 2010. TUPE0426 (abstr).
76. Mimiaga, MJ, Safren, SA, Dvoryak, S, Reisner, SL, Needle, R, Woody, G, ‘We fear the police, and the police fear us’: structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care 22 (2010), 1305–1313.
77. Kerr, T, Small, W, Buchner, C, et al. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. Am J Public Health, 100, 2010, 1449.
78. Kheirandish, P, Seyedalinaghi, SA, Hosseini, M, et al. Prevalence and correlates of HIV infection among male injection drug users in detention in Tehran, Iran. J Acquir Immune Defic Syndr 53 (2010), 273–275.
79. Sarang, A, Rhodes, T, Sheon, N, Page, K, Policing drug users in Russia: risk, fear, and structural violence. Subst Use Misuse 45 (2010), 813–864.
80. Philbin, MM, Zhang, F, Exploring stakeholder perceptions of facilitators and barriers to accessing methadone maintenance clinics in Yunnan Province, China. AIDS Care 22 (2010), 623–629.
81. Shahbazi, M, Farnia, M, Keramati, M, Alasvand, R, Advocacy and piloting the first needle and syringe exchange program in Iranian prisons. Retrovirology, 7(suppl 1), 2010, P81.
82. Pinkerton, SD, Is Vancouver Canada's supervised injection facility cost-saving?. Addiction 105 (2010), 1429–1436.
83. Fairbairn, N, Small, W, Van Borek, N, Wood, E, Kerr, T, Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study. Harm Reduct J, 7, 2010, 20.
84. Bravo, MJ, Royuela, L, Brugal, MT, Barrio, G, Domingo-Salvany, A, Use of supervised injection facilities and injection risk behaviours among young drug injectors. Addiction 104 (2009), 614–619.
85. Ngo, AD, Schmich, L, Higgs, P, Fischer, A, Qualitative evaluation of a peer-based needle syringe programme in Vietnam. Int J Drug Policy 20 (2009), 179–182.
86. Vahdani, P, Hosseini-Moghaddam, SM, Family, A, Moheb-Dezfouli, R, Prevalence of HBV, HCV, HIV, and syphilis among homeless subjects older than fifteen years in Tehran. Arch Iran Med 12 (2009), 483–487.
87. Des Jarlais, DC, Arasteh, K, Hagan, H, McKnight, C, Perlman, DC, Friedman, SR, Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. Am J Public Health 99:suppl 2 (2009), S445–S451.
88. Rafiey, H, Narenjiha, H, Shirinbayan, P, et al. Needle and syringe sharing among Iranian drug injectors. Harm Red J, 6, 2009, 21.
89. Krüsi, A, Small, W, Wood, E, Kerr, T, An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. AIDS Care 21 (2009), 638–644.
90. Hayashi, K, Milloy, MJ, Fairbairn, N, et al. Incarceration experiences among a community-recruited sample of injection drug users in Bangkok, Thailand. BMC Public Health, 9, 2009, 492.
91. Small, W, Wood, E, Betteridge, G, Montaner, J, Kerr, T, The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study. AIDS Care 21 (2009), 708–714.
92. Pollini, RA, Alvelais, J, Gallardo, M, et al. The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend 103 (2009), 52–58.
93. Suntharasamai, P, Martin, M, Vanichseni, S, et al. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999–2003. Addiction 104 (2009), 235–242.
94. Milloy, MJ, Buxton, J, Wood, E, Li, K, Montaner, JS, Kerr, T, Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health, 9, 2009, 156.
95. Thomson, N, Sutcliffe, CG, Sirirojn, B, et al. Correlates of incarceration among young methamphetamine users in Chiang Mai, Thailand. Am J Public Health 99 (2009), 1232–1238.
96. Thanh, DC, Moland, KM, Fylkesnes, K, The context of HIV risk behaviours among HIV-positive injection drug users in Viet Nam: moving toward effective harm reduction. BMC Public Health, 9, 2009, 98.
97. Reid, G, Aitken, C, Advocacy for harm reduction in China: a new era dawns. Int J Drug Policy 20 (2009), 365–370.
98. Sheue-Rong L, Tsuei-Mi H, Hui-Chun H, Lai-Chu S. The successful pilot harm reduction campaign in Taoyuan County. AIDS 2008— XVII International AIDS Conference; Mexico City, Mexico; Aug 3–8, 2008. WEPE1080 (abstr).
99. Schleifer R, Kaplan K, Suwannawong P. Deadly denial: barriers to HIV/AIDS treatment for people who use drugs in Thailand. AIDS 2008—XVII International AIDS Conference; Mexico City, Mexico; Aug 3–8, 2008. TUAE0203 (abstr).
100. Pollini, RA, Brouwer, KC, Lozada, RM, et al. Syringe possession arrests are associated with receptive syringe sharing in two Mexico-US border cities. Addiction 103 (2008), 101–108.
101. Philbin, M, Pollini, RA, Ramos, R, et al. Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment. AIDS Behav 12 (2008), 552–560.
102. Chen, CH, Ko, WC, Lee, HC, Hsu, KL, Ko, NY, Risky behaviors for HIV infection among male incarcerated injection drug users in Taiwan: a case-control study. AIDS Care 20 (2008), 1251–1257.
103. Azim, T, Chowdhury, EI, Reza, M, et al. Prevalence of infections, HIV risk behaviors and factors associated with HIV infection among male injecting drug users attending a needle/syringe exchange program in Dhaka, Bangladesh. Subst Use Misuse 43 (2008), 2124–2144.
104. Miller, CL, Firestone, M, Ramos, R, et al. Injecting drug users' experiences of policing practices in two Mexican-U.S. border cities: public health perspectives. Int J Drug Policy 19 (2008), 324–331.
105. Strathdee, SA, Lozada, R, Pollini, RA, et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J Acquire Immune Defic Syndr 47 (2008), 369–376.
106. Epperson, M, El-Bassel, N, Gilbert, L, Orellana, ER, Chang, M, Increased HIV risk associated with criminal justice involvement among men on methadone. AIDS Behav 12 (2008), 51–57.
107. Milloy, MJ, Wood, E, Small, W, et al. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev 27 (2008), 693–699.
108. Werb, D, Kerr, T, Small, W, Li, K, Montaner, J, Wood, E, HIV risks associated with incarceration among injection drug users: implications for prison-based public health strategies. J Public Health 30 (2008), 126–132.
109. Cohen, JE, Amon, JJ, Health and human rights concerns of drug users in detention in Guangxi Province, China. PLoS Med 5 (2008), 1682–1688.
110. Neaigus, A, Zhao, M, Gyarmathy, VA, Cisek, L, Friedman, SR, Baxter, RC, Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal. J Urban Health 85 (2008), 309–322.
111. Courtenay-Quirk, C, Pals, SL, Kidder, DP, Henny, K, Emshoff, JG, Factors associated with incarceration history among HIV-positive persons experiencing homelessness or imminent risk of homelessness. J Community Health 33 (2008), 434–443.
112. Werb, D, Wood, E, Small, W, et al. Effects of police confiscation of illicit drugs and syringes among injection drug users in Vancouver. Int J Drug Policy 19 (2008), 332–338.
113. Tempalski, B, Cooper, HL, Friedman, SR, Des Jarlais, DC, Brady, J, Gostnell, K, Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug. Int J Drug Policy 19:suppl 1 (2008), 47–58.
114. Sarang, A, Rhodes, T, Platt, L, Access to syringes in three Russian cities: implications for syringe distribution and coverage. Int J Drug Policy 19:suppl 1 (2008), S25–S36.
115. Shannon, K, Kerr, T, Allinott, S, Chettiar, J, Shoveller, J, Tyndall, MW, Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med 66 (2008), 911–921.
116. Raykhert, I, Miskinis, K, Lepshyna, S, et al. HIV seroprevalence among new TB patients in the civilian and prisoner populations of Donetsk Oblast, Ukraine. Scand J Infect Dis 40 (2008), 655–662.
117. Wood, E, Tyndall, MW, Zhang, R, Montaner, JS, Kerr, T, Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction 102 (2007), 916–919.
118. Rich, JD, Hogan, JW, Wolf, F, et al. Lower syringe sharing and re-use after syringe legalization in Rhode Island. Drug Alcohol Depend 89 (2007), 292–297.
119. Rácz, J, Gyarmathy, VA, Neaigus, A, Ujhelyi, E, Injecting equipment sharing and perception of HIV and hepatitis risk among injecting drug users in Budapest. AIDS Care 19 (2007), 59–66.
120. Razani, N, Mohraz, M, Kheirandish, P, et al. HIV risk behavior among injection drug users in Tehran, Iran. Addiction 102 (2007), 1472–1482.
121. Bluthenthal, RN, Ridgeway, G, Schell, T, Anderson, R, Flynn, NM, Kral, AH, Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction 102 (2007), 638–646.
122. Dolan, K, Kite, B, Black, E, Aceijas, C, Stimson, GV, for the for the Reference Group on HIV/AIDS Prevention and Care among Injecting Drug Users in Developing and Transitional Countries. HIV in prison in low-income and middle-income countries. Lancet Infect Dis 7 (2007), 32–41.
123. Rhodes, T, Platt, L, Sarang, A, Vlasov, A, Mikhailova, L, Monaghan, G, Street policing, injecting drug use and harm reduction in a Russian city: a qualitative study of police perspectives. J Urban Health 83 (2006), 911–925.
124. Davis, WR, Johnson, BD, Randolph, D, Liberty, HJ, Risks for HIV infection among users and sellers of crack, powder cocaine and heroin in central Harlem: implications for interventions. AIDS Care 18 (2006), 158–165.
125. Rhodes, T, Platt, L, Maximova, S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction 101 (2006), 252–266.
126. Small, W, Kerr, T, Charette, J, Schechter, MT, Spittal, PM, Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. Int J Drug Policy 17 (2006), 85–95.
127. Tyndall, MW, Wood, E, Zhang, R, Lai, C, Montaner, JSG, Kerr, T, HIV seroprevalence among participants at a supervised injection facility in Vancouver, Canada: implications for prevention, care and treatment. Harm Reduct J, 3, 2006, 36.
128. Zamani, S, Kihara, M, Gouya, MM, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr 42 (2006), 342–346.
129. Miller, CL, Strathdee, SA, Kerr, T, Li, K, Wood, E, Factors associated with early adolescent initiation into injection drug use: implications for intervention programs. J Adolesc Health 38 (2006), 462–464.
130. Sarang, A, Rhodes, T, Platt, L, et al. Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: qualitative study. Addiction 101 (2006), 1787–1796.
131. Callon, C, Wood, E, Marsh, D, Li, K, Montaner, J, Kerr, T, Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. J Opioid Manag 2 (2006), 35–41.
132. Malta, M, Strathdee, SA, Magnanini, MMF, Bastos, FI, Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction 103 (2008), 1242–1257.
133. Global Commission on HIV and the Law. HIV and the law: risks, rights & health, 2012, UNDP, New York, NY.
134. Global Commission on Drug Policy. The war on drugs and HIV/AIDS: how the criminalization of drug use fuels the global pandemic, 2012, Global Commission on Drug Policy, Geneva.